22.05.2017 Views

Review of Pharmacology - 9E (2015)

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Autacoids<br />

Rheumatoid Arthritis<br />

Rheumatoid arthritis (RA) is an autoimmune multisystem disease. NSAIDs are used to provide<br />

symptomatic relief but exert no effect on the progression <strong>of</strong> the disease. Disease modifying anti<br />

rheumatoid drugs (DMARDs) slow the progression <strong>of</strong> disease but act slowly (takes 6 weeks<br />

to 6 months).<br />

A. Corticosteroids<br />

Low-dose corticosteroids can de used as a bridge therapy (until DMARDs start to work) or as<br />

adjunctive therapy (with DMARDs) in rheumatoid arthritis<br />

B. Synthetic DMARDs<br />

1. Methotrexate<br />

It is first choice DMARD and is used at much lower doses (7.5 mg weekly) than required in<br />

cancer chemotherapy (30 mg daily).<br />

Adverse effects <strong>of</strong> methotrexate<br />

• Gastric irritation and stomatitis (most common)<br />

• Pancytopenia<br />

• Hepatotoxicity with fibrosis and cirrhosis Risk factors are:<br />

v Chronic hepatitis<br />

v Heavy alcohol consumption<br />

v Diabetes mellitus<br />

v Obesity<br />

v Kidney disease<br />

• Interstitial pneumonitis (Hypersensitivity reaction)<br />

• Teratogenicity<br />

• Increased risk <strong>of</strong> B-cell lymphomas<br />

• Amoxycillin and probenecid increase risk <strong>of</strong> methotrexate toxicity<br />

Methotrexate is first choice<br />

DMARD<br />

Leflunomide is a prodrug (converted<br />

in the body to an active<br />

metabolite) that inhibits the enzyme<br />

dihydro orotate dehydrogenase.<br />

General Autacoids <strong>Pharmacology</strong><br />

2. Sulfasalazine<br />

It is metabolized to sulfapyridine and 5-aminosalicylic acid. Former is the active moiety in<br />

RA and latter is useful for ulcerative colitis. It is used in patients when methotrexate is<br />

contraindicated.<br />

3. Leflunomide<br />

It is a prodrug (converted in the body to an active metabolite) that inhibits the enzyme<br />

dihydro orotate dehydrogenase. This enzyme is required for pyrimidine synthesis and thus<br />

growth <strong>of</strong> B cells is arrested by leflunomide. Cholestyramine decreases its toxicity by enhancing<br />

its clearance. It is faster acting (action is manifested in 4 weeks as compared to 3 months with<br />

N<br />

Teriflunomide is dihydro-orotate<br />

dehydrogenase inhibitor (like<br />

leflunomide). It is indicated for<br />

relapsing-remitting multiple<br />

sclerosis.<br />

121<br />

https://kat.cr/user/Blink99/

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!